“Immuno-Oncology Therapeutics” Featuring Dr. Michael Alonso

On this episode of the Immunology Podcast, Dr. Michael Alonso from Bolt Biotherapeutics talks about using myeloid cells to target tumors.

Dr. Michael Alonso is a Scientific Co-Founder and Vice President of Immunology & Pharmacology at Bolt Biotherapeutics, a biotechnology company developing immunotherapies that activate myeloid cells. He discusses targeting tumors by covering them in “eat me” signals, considerations for moving drugs into the clinic, and building teams in biotech.

We had such an inspiring conversation with Dr. Alonso about science, entrepreneurship, and embracing challenges head on!

Dr. Brenda Raud, host

Find more episodes at immunologypodcast.com or wherever you get your podcasts.

This Episode's Immunology Roundup:

Publish Date: November 02, 2022